Progyny Price Earnings To Growth Ratio Over Time
| PGNY Stock | USD 15.44 0.47 3.14% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Progyny Performance and Progyny Correlation. Progyny |
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Progyny. If investors know Progyny will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Progyny listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.31) | Earnings Share 0.6 | Revenue Per Share 12.279 | Quarterly Revenue Growth 0.02 | Return On Assets 0.059 |
The market value of Progyny is measured differently than its book value, which is the value of Progyny that is recorded on the company's balance sheet. Investors also form their own opinion of Progyny's value that differs from its market value or its book value, called intrinsic value, which is Progyny's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Progyny's market value can be influenced by many factors that don't directly affect Progyny's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Progyny's value and its price as these two are different measures arrived at by different means. Investors typically determine if Progyny is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Progyny's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Price Earnings To Growth Ratio Analysis
Compare Progyny and related stocks such as Veeva Systems Class, Teladoc, and Goodrx Holdings Price Earnings To Growth Ratio Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VEEV | 25.4035 | 25.4035 | 0.4436 | 0.2662 | 1.6537 | 1.8299 | 2.1393 | 0.6944 | 2.0515 | 1.8558 | 4.7673 | 7.9163 | 4.3315 | 15.298 | 16.06 |
| TDOC | (0.1694) | (0.1694) | (0.1694) | (0.1694) | (0.1694) | (0.0167) | 0.2361 | (1.7587) | 1.4106 | 9.9371 | (0.1294) | 0.6849 | (1.0E-4) | 0.1612 | 0.15 |
| GDRX | (10.3148) | (10.3148) | (10.3148) | (10.3148) | (10.3148) | (10.3148) | (10.3148) | (10.3148) | 0.9684 | (35.3596) | 0.0688 | 5.6588 | (2.2377) | 4.2565 | 4.47 |
| TXG | (0.015) | (0.015) | (0.015) | (0.015) | (0.015) | (0.015) | (0.015) | (0.015) | (0.015) | 1.0535 | (0.0462) | 3.1323 | (0.1424) | (0.5212) | (0.5) |
| DH | (0.1743) | (0.1743) | (0.1743) | (0.1743) | (0.1743) | (0.1743) | (0.1743) | (0.1743) | (0.1743) | (0.1743) | (0.1743) | 1.443 | 0.7673 | (0.0078) | (0.0074) |
| NRC | 0.4389 | 0.4226 | 0.4052 | (0.3519) | 0.9871 | (4.8532) | 1.3456 | 3.8691 | 0.3258 | 2.9492 | 2.0857 | (41.6957) | (2.2617) | (20.0611) | (19.06) |
| EVH | (0.36) | (0.36) | (0.36) | (0.36) | 0.025 | (4.0E-4) | 0.0328 | 0.1775 | 1.0593 | (0.0055) | (0.657) | 0.863 | 3.2828 | (0.0602) | (0.0572) |
| SLP | (5.0329) | (5.0329) | (5.0329) | 1.1631 | 1.1631 | 1.1631 | 2.5051 | 0.7638 | (12.7556) | 18.5817 | (15.7349) | 3.6619 | (4.6326) | (5.33) | (5.06) |
| PRVA | (0.8113) | (0.8113) | (0.8113) | (0.8113) | (0.8113) | (0.8113) | (0.8113) | (0.8113) | (0.8113) | (0.8113) | 0.2734 | 0.0212 | 2.2219 | (0.4133) | (0.39) |
| HSTM | (0.1038) | 0.9442 | (12.8779) | 15.0928 | 3.4629 | (3.2386) | (3.6099) | 0.4659 | 0.1087 | (0.9971) | (2.503) | (2.503) | 0.5982 | 1.9258 | 2.02 |
| CERT | 8.6812 | 8.6812 | 8.6812 | 8.6812 | 8.6812 | 8.6812 | 8.6812 | 8.6812 | 8.6812 | 8.6812 | (0.2249) | 4.4373 | (0.8304) | 0.1068 | 0.1 |
| PHR | 0.0992 | 0.0992 | 0.0992 | 0.0992 | 0.0992 | 0.0992 | 0.0992 | 0.0992 | 0.0992 | 0.3534 | 3.1175 | (0.0541) | (0.2672) | 0.4015 | 0.67 |
| HCAT | (0.5492) | (0.5492) | (0.5492) | (0.5492) | (0.5492) | (0.5492) | (0.5492) | (0.5492) | (0.5492) | (0.2462) | 1.6012 | (1.1169) | 0.2004 | 0.2409 | 0.25 |
Progyny and related stocks such as Veeva Systems Class, Teladoc, and Goodrx Holdings Price Earnings To Growth Ratio description
My Equities
My Current Equities and Potential Positions
| Progyny | PGNY |
Specialization | Health Care, Health Care Equipment & Services |
| Location | New York; U.S.A |
| Exchange | NASDAQ Exchange |
USD 15.44
Additional Tools for Progyny Stock Analysis
When running Progyny's price analysis, check to measure Progyny's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Progyny is operating at the current time. Most of Progyny's value examination focuses on studying past and present price action to predict the probability of Progyny's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Progyny's price. Additionally, you may evaluate how the addition of Progyny to your portfolios can decrease your overall portfolio volatility.